U.S. flag

An official website of the United States government

NM_001999.4(FBN2):c.4249C>T (p.His1417Tyr) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 24, 2014
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000198694.1

Allele description [Variation Report for NM_001999.4(FBN2):c.4249C>T (p.His1417Tyr)]

NM_001999.4(FBN2):c.4249C>T (p.His1417Tyr)

Gene:
FBN2:fibrillin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q23.3
Genomic location:
Preferred name:
NM_001999.4(FBN2):c.4249C>T (p.His1417Tyr)
HGVS:
  • NC_000005.10:g.128330669G>A
  • NG_008750.1:g.212375C>T
  • NM_001999.4:c.4249C>TMANE SELECT
  • NP_001990.2:p.His1417Tyr
  • NC_000005.9:g.127666361G>A
  • NM_001999.3:c.4249C>T
  • p.H1417Y
Protein change:
H1417Y
Links:
dbSNP: rs863223572
NCBI 1000 Genomes Browser:
rs863223572
Molecular consequence:
  • NM_001999.4:c.4249C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000250208GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Mar 24, 2014)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000250208.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.His1417Tyr (CAC>TAC): c.4249 C>T in exon 33 of the FBN2 gene (NM_001999.3) The H1417Y variant has not been published as a mutation or has it been reported as a benign polymorphism to our knowledge. The H1417Y variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The H1417Y variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In silico analysis predicts this variant is probably damaging to the protein structure/function. Located in the EGF-like 23 calcium-binding domain, missense mutations in the same domain (D1408N, C1425R, C1425Y, 1425F) have been reported in association with congenital contractural arachnodactyly, supporting the functional importance of this region of the protein. Therefore, this variant is a strong candidate for a pathogenic mutation, however the possibility that it is a benign variant cannot be excluded. This variant was found in TAAD

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 5, 2022